DocGo Inc.
DCGONASDAQHealthcare● Active
$0.55
$-0.01(-2.52%)
Market Cap$53844106
P/E Ratio—
52W High$1.78
52W Low$0.491
DocGo Inc. (DCGO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DCGO · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.12
Est. -$0.02 · -500.0%
Revenue
$0.08B
Est. $0.07B · +4.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
DCGO reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.10 | — | — | — | $0.08B | — |
| ▼ Q2 FY2026 | May 11, 2026 | -$0.02 | -$0.12 | -500.0% | $0.08B | $0.07B | +4.2% |
| ▼ Q1 FY2026 | Mar 16, 2026 | -$0.10 | -$0.53 | -430.0% | $0.07B | $0.07B | +6.6% |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$0.15 | -$0.11 | +26.2% | $0.07B | $0.07B | +0.7% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$0.10 | -$0.11 | -10.0% | $0.08B | $0.07B | +16.7% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.03 | -$0.09 | -184.2% | $0.10B | $0.10B | -3.1% |
| ▼ Q1 FY2025 | Feb 27, 2025 | $0.05 | $0.04 | -20.0% | $0.12B | $0.11B | +8.0% |
| — Q4 FY2024 | Nov 7, 2024 | $0.05 | $0.05 | +0.0% | $0.14B | $0.13B | +7.2% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.10
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Miss
EPS Actual
-$0.12
EPS Est.
-$0.02
EPS Surpr.
-500.0%
Revenue
$0.08B
Q1 FY2026
Mar 16, 2026Miss
EPS Actual
-$0.53
EPS Est.
-$0.10
EPS Surpr.
-430.0%
Revenue
$0.07B
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
-$0.11
EPS Est.
-$0.15
EPS Surpr.
+26.2%
Revenue
$0.07B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$0.11
EPS Est.
-$0.10
EPS Surpr.
-10.0%
Revenue
$0.08B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.09
EPS Est.
-$0.03
EPS Surpr.
-184.2%
Revenue
$0.10B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.05
EPS Surpr.
-20.0%
Revenue
$0.12B
Q4 FY2024
Nov 7, 2024
EPS Actual
$0.05
EPS Est.
$0.05
EPS Surpr.
+0.0%
Revenue
$0.14B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q1 FY2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q4 FY2026 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2026 | $-0.13 | $-0.06 | $0.01 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 11, 2026 | -500.0% | $0.57 | $0.59 | +3.81% |
| ▼ Q1 FY2026 | Mar 16, 2026 | -430.0% | $0.66 | $0.65 | -1.48% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +26.2% | $1.11 | $1.11 | +0.00% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -10.0% | $1.41 | $1.39 | -1.42% |
| ▼ Q2 FY2025 | May 8, 2025 | -184.2% | $2.40 | $2.33 | -2.92% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -20.0% | $4.06 | $3.92 | -3.45% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +0.0% | $3.65 | $3.61 | -1.10% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -12.5% | $3.07 | $2.99 | -2.61% |
Q2 FY2026+3.81%
Report Date
May 11, 2026
EPS Beat/Miss
-500.0%
Price Before
$0.57
Price After
$0.59
Q1 FY2026-1.48%
Report Date
Mar 16, 2026
EPS Beat/Miss
-430.0%
Price Before
$0.66
Price After
$0.65
Q4 FY2025+0.00%
Report Date
Nov 10, 2025
EPS Beat/Miss
+26.2%
Price Before
$1.11
Price After
$1.11
Q3 FY2025-1.42%
Report Date
Aug 7, 2025
EPS Beat/Miss
-10.0%
Price Before
$1.41
Price After
$1.39
Q2 FY2025-2.92%
Report Date
May 8, 2025
EPS Beat/Miss
-184.2%
Price Before
$2.40
Price After
$2.33
Q1 FY2025-3.45%
Report Date
Feb 27, 2025
EPS Beat/Miss
-20.0%
Price Before
$4.06
Price After
$3.92
Q4 FY2024-1.10%
Report Date
Nov 7, 2024
EPS Beat/Miss
+0.0%
Price Before
$3.65
Price After
$3.61
Q3 FY2024-2.61%
Report Date
Aug 7, 2024
EPS Beat/Miss
-12.5%
Price Before
$3.07
Price After
$2.99
Avg Beat Reaction-0.55%
Avg Miss Reaction-1.34%
Beat Rate2 / 8 quarters
Largest Move+3.81% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DCGO ends December
DocGo Inc. (DCGO) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.12 — missing the analyst consensus of $-0.02 by -500.0%. The next DCGO earnings date is expected around September 1, 2026.
Each quarter, investors track DCGO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DCGO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DCGO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DCGO earnings · 5 questionsDocGo Inc.'s next earnings report is expected around September 1, 2026. DCGO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DCGO historically reports after market close (AMC).
DCGO earnings datewhen is DCGO earningsDCGO next earnings datewhen does DCGO report earningsDCGO earnings calendar
▸ Source: FMP · DocGo Inc. SEC filings · US GAAP · DocGo Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026